XREF LIMITED — Interim / Quarterly Report 2019

Apr 29, 2019

Appendix 4C

==> picture [147 x 35] intentionally omitted <==

Quarterly report for entities subject to Listing Rule 4.7B

Name of entity Xref Limited

Xref Limited
ACN 122 404 666 Consolidated statement of cash flows	Quarter ended ("current quarter")
	31 March 2019
1 Cash flows from operating activities 1.1 Receipts from customers 1.2 Payments for (a) research and development (b) product manufacturing and operating costs (c) advertising and marketing (d) leased assets (e) staff costs (f) administration and corporate costs 1.3 Dividends received 1.4 Interest received 1.5 Interest and other costs of finance paid 1.6 Income taxes paid 1.7 Government grants and tax incentives 1.8 Other (provide details if material) - Net GST/VAT for the period_(refer note page 3)_ - Net foreign exchange gain 1.9 Net cash from / (used in) operating activities	Current quarter $A'000 2,167 (8) (183) (402) (184) (2,580) (709) 44 (108) 25	Year to date (9 months) $A'000 6,965 (18) (378) (1,049) (558) (8,177) (1,448) 101 1,453 (165) (55)
	(1,938)	(3,329)
2 Cash flows from investing activities 2.1 Payments to acquire (a) property, plant and equipment (b) businesses (item 10) (c) investments (d) intellectual property (e) other non-current assets 2.2 Proceeds from disposal of: (a) property, plant and equipment (b) businesses (item 10) (c) investments (d) intellectual property (e) other non-current assets 2.3 Cash flows from loans to other entities 2.4 Dividends received (see note 3) 2.5 Other (provide details if material) - 2.6 Net cash from / (used in) investing activities	(39) - - - - - - - - - - - -	(78) - - - - - - - - - - - -
	(39)	(78)

Xref Limited

Page 1 of 3

Appendix 4C - 31 March 2019

3 3.1 3.2 3.3 Proceeds from exercise of share options 3.4 3.5 Proceeds from borrowings 3.6 Repayment of borrowings 3.7 3.8 Dividends paid 3.9 Other (provide details if material) 3.10 Net cash from / (used in) financing activities Transaction costs related to issues of shares, convertible notes or options Transaction costs related to loans and borrowings Cash flows from financing activities Proceeds from issues of shares Proceeds from issue of convertible notes	Current quarter $A'000 458 (3) - - - -	Year to date (9 months) $A'000 9,037 (488) - - - -
	455	8,549
4 4.1 4.2 4.3 4.4 4.5 Effect of movement in exchange rates on cash held 4.6 Cash and cash equivalents at end of quarter Net increase (decrease) in cash and cash equivalents for the period held Cash and cash equivalents at beginning of quarter /year to date Net cash from / (used in) operating activities (item 1.9 above) Net cash from / (used in) investing activities (item 2.6 above) Net cash from / (used in) financing activities (item 3.10 above)	Current quarter $A'000 11,113 (1,938) (39) 455 3	Year to date (9 months) $A'000 4,452 (3,329) (78) 8,549 -
	9,594	9,594
5 Reconciliation of cash and cash equivalents 5.1 Bank balances 5.2 Call deposits 5.3 Bank overdrafts 5.4 Other (provide details) 5.5 Cash and cash equivalents at end of at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts	Current quarter $A'000 9,519 75 - -	Previous quarter $A'000 11,038 75 - -
	9,594	11,113
6 6.1 6.2 Payments to directors of the entity and associates of the directors Aggregate amount of payments to these parties included in item 1.2 Aggregate amount of cash flow from loans to these parties included in item 2.3	Current quarter $A'000 202
	Current quarter $A'000 202
6.3 Include below any explanation necessary to understand the transactions included in items 6.1 and 6.2

Xref Limited

Page 2 of 3

Appendix 4C - 31 March 2019

• 7 Payments to related entities of the entity Current and associates of the related entities quarter $A'000

• 7.1 Aggregate amount of payments to these parties included in item 1.2 - 7.2 Aggregate amount of cash flow from loans to these parties included in item 2.3 - 7.3 Include below any explanation necessary to understand the transactions included in 7.1 and 7.2

8 Financing facilities available

Add notes as necessary for an understanding Total facility of the position. amount at Amount drawn at quarter end quarter end $A'000 $A'000 8.1 Loan facilities - - 8.2 Credit standby arrangements - - 8.3 Other (please specify) - - 8.4 Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.

9 Estimated cash outflows for next quarter 9.1 Research and Development 9.2 Product manufacturing and operating costs 9.3 Advertising and marketing 9.4 Leased assets 9.5 Staff costs 9.6 Administration and corporate costs 9.7 Other (provide details if material) 9.8 Total estimated cash outflows 10 10.1 Name of entity 10.2 Place of incorporation or registration 10.3 Consideration for acquisition or disposal 10.4 Total net assets 10.5 Nature of business Acquisitions and disposals of business	$A'000 10 130 400 190 2820 540	$A'000 10 130 400 190 2820 540
	4,090
	Acquisitions	Disposals
	n/a	n/a

Compliance statement

1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule 19.11A.

• 2 This statement does give a true and fair view of the matters disclosed.

==> picture [60 x 46] intentionally omitted <==

Sign here:

Print name: James Solomons, CFO

Date: 29 April 2019

Note:

In previously lodged Appendix 4C, line 1.8 'GST on Sales for the period' only reflected GST/VAT Collected in that period. The sum of GST/VAT paid on expenses for the period was reported in Line 1.2(f). To better represent the business outflows, the net of GST collected & paid plus actual payments made to tax authorities is now shown in line 1.8. The previous period adjusment was made to the YTD figure of Line 1.2(f)

Xref Limited

Page 3 of 3

Appendix 4C - 31 March 2019